The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
Open accessAbstract
OBJECTIVE: To evaluate the use of prospective screening for the HLA-B*58:01 allele to identify Taiwanese individuals at risk of severe cutaneous adverse reactions (SCARs) induced by allopurinol treatment. DESIGN: National prospective cohort study. SETTING: 15 medical centres in different regions of Taiwan, from July 2009 to August 2014. PARTICIPANTS: 2926 people who had an indication for allopurinol treatment but had not taken allopurinol previously. Participants were excluded if they had undergone a bone marrow transplant, were not of Han Chinese descent, and had a history of allopurinol induced hypersensitivity. DNA purified from 2910 participants' peripheral blood was used to assess the presence of HLA-B*58:01. MAIN OUTCOME MEASURES: Incidence of allopurinol induced SCARs with and without screening. RESULTS: Participants who tested positive for HLA-B*58:01 (19.6%, n=571) were advised to avoid allopurinol, and were referred to an alternate drug treatment or advised to continue with their prestudy treatment. Participants who tested negative (80.4%, n=2339) were given allopurinol. Participants were interviewed once a week for two months to monitor symptoms. The historical incidence of allopurinol induced SCARs, estimated by the National Health Insurance research database of Taiwan, was used for comparison. Mild, transient rash without blisters developed in 97 (3%) participants during follow-up. None of the participants was admitted to hospital owing to adverse drug reactions. SCARs did not develop in any of the participants receiving allopurinol who screened negative for HLA-B*58:01. By contrast, seven cases of SCARs were expected, based on the estimated historical incidence of allopurinol induced SCARs nationwide (0.30% per year, 95% confidence interval 0.28% to 0.31%; P=0.0026; two side one sample binomial test). CONCLUSIONS: Prospective screening of the HLA-B*58:01 allele, coupled with an alternative drug treatment for carriers, significantly decreased the incidence of allopurinol induced SCARs in Taiwanese medical centres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Path to Personalized Medicine
Hamburg, M. A., & Collins, F. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmp1006304 · Cited by 1,970
An agenda for personalized medicine
Ng, P. C., Murray, S. S., Levy, S., & Venter, J. C. (2009) · Nature · doi:10.1038/461724a · Cited by 330
Cited by
2016 updated EULAR evidence-based recommendations for the management of gout
Richette, P., Doherty, M., Pascual, E., Barskova, V, Becce, F., Castañeda-Sanabria, J., Coyfish, M., Guillo, S., Jansen, T. L., Janssens, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209707 · Cited by 1,681
Pascart, T., Wasik, K. A., Preda, C., Chune, V., Torterat, J., Prud’homme, N., Nassih, M., Martin, A., Le Masson, J., Rodière, V., et al. (2024) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00012-3 · Cited by 39
Huang, Y., Wu, C., Chang, T., Peng, C., Lo, G., Hsu, C., Hu, C., & Huang, Y. (2021) · Liver International · doi:10.1111/liv.14990 · Cited by 20
Self-citation
Metadata
- Authors
- Ko, T.-M., Tsai, C.-Y., Chen, S.-Y., Chen, K.-S., Yu, K.-H., Chu, C.-S., Huang, C.-M., Wang, C.-R., Weng, C.-T., Yu, C.-L., Hsieh, S.-C., Tsai, J.-C., Lai, W.-T., Tsai, W.-C., Yin, G.-D., Ou, T.-T., Cheng, K.-H., Yen, J.-H., Liou, T.-L., Lin, T.-H., Chen, D.-Y., Hsiao, P.-J., Weng, M.-Y., Chen, Y.-M., Chen, C.-H., Liu, M.-F., Yen, H.-W., Lee, J.-J., Kuo, M.-C., Wu, C.-C., Hung, S.-Y., Luo, S.-F., Yang, Y.-H., Chuang, H.-P., Chou, Y.-C., Liao, H.-T., Wang, C.-W., Huang, C.-L., Chang, C.-S., Lee, M.-T. M., Chen, P., Wong, C.-S., Chen, C.-H., Wu, J.-Y., Chen, Y.-T., & Shen, C.-Y.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2015-09-23
- Volume
- 351
- Pages
- h4848
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2262559384
- Cited by
- 209
- References
- 2
- FWCI
- 15.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. https://app.cochat.ai/papers/10.1136/bmj.h4848
- The paper
- Ko, T.-M., Tsai, C.-Y., Chen, S.-Y., Chen, K.-S., Yu, K.-H., Chu, C.-S., Huang, C.-M., Wang, C.-R., Weng, C.-T., Yu, C.-L., Hsieh, S.-C., Tsai, J.-C., Lai, W.-T., Tsai, W.-C., Yin, G.-D., Ou, T.-T., Cheng, K.-H., Yen, J.-H., Liou, T.-L., . . . Shen, C.-Y. (2015). Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ. https://doi.org/10.1136/bmj.h4848
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.